Werner Schmitz
Impact in
- Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in ⓘ
-
- Metabolism and Genetic Disorders 12
- Biochemistry 10
- Co-authors
- Ernst Conzelmann (19 shared papers)Ralph Fingerhut (4 shared papers)J. Kalervo Hiltunen (17 shared papers)Thomas D. Mueller (8 shared papers)Rik K. Wierenga (16 shared papers)Almut Schulze (11 shared papers)W. Mehlhorn (3 shared papers)Walter Sebald (6 shared papers)
- Journals
- Biochemical Journal (8 papers)Journal of Biological Chemistry (4 papers)European Journal of Biochemistry (4 papers)Nature Communications (3 papers)FEBS Journal (3 papers)
- Partner nations
- GermanyFinlandUnited States
In The Last Decade
Werner Schmitz
133 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Clinical Biochemistry 261
- Cancer Research 564
- Molecular Biology 1.9k
- Biochemistry 167
- Catalysis 115
Countries citing papers authored by Werner Schmitz
This map shows the geographic impact of Werner Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Schmitz more than expected).
Fields of papers citing papers by Werner Schmitz
This network shows the impact of papers produced by Werner Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Schmitz. The network helps show where Werner Schmitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Werner Schmitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 280 | |
| 2 | Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming Hit paper breakdown → | 2023 | 135 |
| 3 | 1995 | 107 | |
| 4 | 2009 | 107 | |
| 5 | 1994 | 105 | |
| 6 | 2004 | 94 | |
| 7 | 2014 | 92 | |
| 8 | 1997 | 88 | |
| 9 | 2001 | 76 | |
| 10 | 2019 | 66 | |
| 11 | 2004 | 65 | |
| 12 | 2004 | 64 | |
| 13 | 2009 | 62 | |
| 14 | 2020 | 60 | |
| 15 | 2023 | 58 | |
| 16 | 2006 | 54 | |
| 17 | 2000 | 53 | |
| 18 | 2005 | 52 | |
| 19 | 2000 | 48 | |
| 20 | 2009 | 47 |
About Werner Schmitz
Werner Schmitz is a scholar working on Clinical Biochemistry, Biochemistry, Inorganic Chemistry, Materials Chemistry and Cancer Research, having authored 138 papers that have together received 3.4k indexed citations. Recurring topics across this work include Enzyme Structure and Function (20 papers), Peroxisome Proliferator-Activated Receptors (17 papers), Metabolism and Genetic Disorders (12 papers), Zeolite Catalysis and Synthesis (11 papers), Cancer, Hypoxia, and Metabolism (10 papers), Microbial Metabolic Engineering and Bioproduction (7 papers), Drug Transport and Resistance Mechanisms (7 papers) and Solid-state spectroscopy and crystallography (7 papers). The work is most often cited by research in Clinical Biochemistry (261 citations), Cancer Research (564 citations), Molecular Biology (1.9k citations), Biochemistry (167 citations) and Catalysis (115 citations). Werner Schmitz has collaborated with scholars based in Germany, Finland and United States. Frequent co-authors include Ernst Conzelmann, Ralph Fingerhut, J. Kalervo Hiltunen, Thomas D. Mueller, Rik K. Wierenga, Almut Schulze, W. Mehlhorn, Walter Sebald, G. Wendt and Mathias T. Rosenfeldt. Their work appears in journals such as Biochemical Journal, Journal of Biological Chemistry, European Journal of Biochemistry, Nature Communications and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.